Biospecimen Acquisition From Human Subjects

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and older with cancer may participate. This study does not involve treatment. Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their condition, patients may be invited to enroll in a clinical research study involving chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during the course of treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Note: Effective with Amendment CC, participants will no longer be asked to undergo apheresis. This content is being retained for historical reference.

• Hemoglobin greater than or equal to 10 mg/dL and platelet count \> 75,000/mm(3)

• Weight greater than 25 kg

• HIV negative

• Prothrombin Time - within normal limits

• Partial Thromboplastin Time - within normal limits

• Medically indicated central line in place or adequate peripheral venous access

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Michell J Manu, R.N.
michell.manu@nih.gov
(240) 529-3415
Backup
Jennifer L Marte
martej@mail.nih.gov
(301) 496-7214
Time Frame
Start Date: 2002-07-16
Participants
Target number of participants: 1750
Treatments
Healthy Volunteers
Healthy volunteers 18 years of age and older
Participants
Participants with cancer 18 years of age and older
Authors
Jennifer L Marte, James L Gulley
Sponsors
Leads: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov